Dr. Jeffrey Jacobson, World-Renowned HIV Clinical Researcher, Joins Temple
Jeffrey Jacobson, MD, has been appointed Professor of Medicine, Professor of Neuroscience and Professor in the Center for Neurovirology at the Lewis Katz School of Medicine at Temple University (LKSOM). Dr. Jacobson is a nationally and internationally-renowned expert in clinical research on HIV and other chronic viral infections.
Board-certified in Internal Medicine and Infectious Diseases, Dr. Jacobson earned his medical degree from Cornell University Medical College. He completed his internship in Medicine at the University of Wisconsin Hospital and Clinics, and both an Internal Medicine residency and Infectious Diseases fellowship at Mount Sinai Medical Center in New York. Prior to joining Temple, Dr. Jacobson was Professor of Medicine at Albert Einstein College of Medicine in New York and Professor of Medicine, Microbiology and Immunology at the Drexel University College of Medicine.
“Anytime you can add a world-renowned researcher to your organization you are doing something right, and that’s exactly what we are doing with the addition of Dr. Jacobson at Temple,” says Joseph Y. Cheung, MD, PhD, FACP, FAHA, FCPP, Richard Laylord & Dorothy L. Evans Professor and Chair of the Department of Medicine, and Professor in the Center for Translational Medicine at LKSOM. “His arrival will allow us to take our ever-expanding clinical research enterprise to the next level.”
Dr. Jacobson has chaired numerous clinical research studies involving the pathogenesis, pharmacokinetics and treatment of HIV inside and outside of the National Institutes of Health (NIH)-sponsored AIDS Clinical Trials Group (ACTG). He chaired several ACTG committees, including the Immunology Committee and the Translational Research and Drug Development Committee, and has been a member of the Scientific Agenda Steering Committee of the ACTG. Dr. Jacobson also co-chaired the Long Acting Drug Task Force in the ACTG, and currently chairs the Microbiome Focus Group and co-chairs the Therapeutic Vaccination Focus Group. He has been a member of many academic and industry Scientific Advisory Boards, as well as Data Safety Monitoring Boards.
Since 2002, Dr. Jacobson’s clinical research has been funded by the NIH, most notably as Principal Investigator and Co-Investigator on many National Institute of Allergy and Infectious Diseases (NIAID) and National Institute on Drug Abuse (NIDA) award-funded studies. He is also successful in securing HIV research funding from pharmaceutical companies. Dr. Jacobson is the Clinical Leader of Temple’s NIH-funded Comprehensive NeuroAIDS Center, of which Kamel Khalili, PhD, serves as Program Director. Dr. Jacobson is bringing more than $1.5 million in research funding to Temple for the current year.
“Temple has been a leader in basic science research and discovery in the field of HIV/AIDS and other viral infections,” says Dr. Khalili, who is also Laura H. Carnell Professor and Chair of the Department of Neuroscience and Director of the Center for Neurovirology at LKSOM. “The importance of Dr. Jacobson’s arrival cannot be overstated as we work to move our research from the bench to the bedside through clinical trials.”
“I’m pleased and excited to be joining the exceptional team at Temple,” says Dr. Jacobson. “We are currently in an age of rapid development and discovery of new treatments for HIV/AIDS and we are continually taking additional steps toward a permanent cure.”
Dr. Jacobson has 118 peer-reviewed publications in high impact journals such as New England Journal of Medicine, Lancet, Nature Medicine, Journal of Infectious Diseases and Annals of Internal Medicine. Dr. Jacobson has earned many honors including placement on the list of the “Top Doctors in America” and “Best Doctors in America”, as well as the Clinical Research Scientist Award and Honored Member of Strathmore’s “Who’s Who.”
As Professor of Medicine and Neuroscience at LKSOM, Dr. Jacobson will focus on building the AIDS Clinical Research Program. He will serve as Co-Director (along with Dr. Khalili) of the newly established Center of Translational AIDS Research (CTAR), with Temple at the central hub, in collaboration with colleagues at Drexel University College of Medicine and the Perelman School of Medicine at the University of Pennsylvania. Dr. Jacobson will also continue to serve in the AIDS Clinical Trials Group at the University of Pennsylvania.